NFA
IRMD icon

Nationwide Fund Advisors’s iRadimed IRMD Stock Holding History

Nationwide Fund Advisors’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,215
Closed -$20K – 3230
2017
Q1 		$20K Hold
2,215
– – ﹤0.01% 3087
2016
Q4 		$25K Hold
2,215
– – ﹤0.01% 3071
2016
Q3 		$38K Hold
2,215
– – ﹤0.01% 3082
2016
Q2 		$48K Buy
2,215
+459
+26% +$8.26K ﹤0.01% 3082
2016
Q1 		$34K Hold
1,756
– – ﹤0.01% 3044
2015
Q4 		$49K Hold
1,756
– – ﹤0.01% 2995
2015
Q3 		$43K Hold
1,756
– – ﹤0.01% 3041
2015
Q2 		$41K Buy
+1,756
New +$32.1K ﹤0.01% 3111

Other funds holding IRMD

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Nationwide Fund Advisors's IRMD Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of iRadimed (IRMD) in Q2 2017, closing a stake of 2,215 shares — an estimated $20K sold.

Nationwide Fund Advisors first reported a position in IRMD in Q2 2015 and held it in 8 quarters. The position peaked at $49K in Q4 2015. 35 funds tracked by Wall St. Rank hold IRMD as of Q2 2017.

  • Nationwide Fund Advisors reported no remaining iRadimed position as of Q2 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 2,215 iRadimed shares in Q2 2017, an estimated $20K.
  • Nationwide Fund Advisors first reported a position in iRadimed in Q2 2015 and held it in 8 quarters.
  • Nationwide Fund Advisors's iRadimed position peaked at $49K in Q4 2015.
  • 35 funds tracked by Wall St. Rank held iRadimed as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.